Self-perceived stigma and motor symptoms in patients with Parkinson’s disease
Objective: To identify the variables of activities of daily living (ADL) and motor function associated with self-perceived stigma (self-stigma) in patients with Parkinson’s disease (PD).…Prevalence, Impact, and Suboptimal Treatment of Depression in the Fox Insight Cohort
Objective: Addressing unmet mental health needs in Parkinson’s disease (PD) requires delineating their scope and impact. This study evaluated (1) depressive symptom prevalence and treatment…Impulse control disorder and ventral striatum dopamine D3 receptor availability in Parkinson’s disease
Objective: To investigate the relationship between ventral striatum D3 dopamine receptor availability and severity of impulse control disorder (ICD) in Parkinson’s disease (PD). Background: Reduced…Triggers and Alleviating Factors for Fatigue in Parkinson’s Disease
Objective: To examine self-reported triggers of fatigue for individuals with Parkinson’s Disease (PD), the strategies they employ to cope with fatigue, and the types of…Rates of Pharmacological Treatment of Neuropsychiatric Symptoms in Early Parkinson’s Disease
Objective: To determine the rates of pharmacological treatment for neuropsychiatric symptoms (NPS) in patients with early Parkinson’s disease (PD), and identify predictors of under-treatment. Background:…The dysfunctional autonomic function and “dysfunctional” fatigue in drug naïve Parkinson’s disease
Objective: In the present study, the relationship between fatigue and autonomic dysfunction in drug-naïve PD patients was investigated. Background: Fatigue is a common and disabling…Orthostatic hypotension in early onset Parkinson’s disease
Objective: To investigate Orthostatic hypotension (OH) feature in early onset Parkinson's disease (EOPD) , especially delayed OH and acute OH post drug. To explore OH…Impact of safinamide on non-motor and motor experiences of daily living: Primary results from the prospective, observational ProGo study
Objective: Evaluate the effect of safinamide treatment on non-motor and motor experiences of daily living as assessed using the MDS-UPDRS (Parts I nm-EDLand II m-EDL).…Progression in Parkinson’s disease: Variation in motor and non-motor symptoms severity and predictors of decline in cognition, motor function, incapacity and Health Related Quality of Life
Objective: Assess the progression of motor and non-motor symptoms in Parkinson's Disease (PD) and predictors of cognitive, motor, activities of daily living (ADL) and Health…Functional Hearing Impairment Common In Parkinson’s Disease: Insights From A Pilot Study
Objective: The primary objective of this pilot study was to investigate hearing and its relationship to the neuropsychiatric profile, cognition and quality of life in…
- « Previous Page
- 1
- …
- 28
- 29
- 30
- 31
- 32
- …
- 55
- Next Page »